Replies to post #3295 on GTC Biotherapeutics (fka GTCB)

[DewDiligence]

Worth noting: No GTC insiders exercised options during 2006 nor during 2007 to date.

[DewDiligence]

Current Insider Shareholdings and Options

[As of May 23, 2007. Options include those that are exercisable now or within 60 days.]

 
  
 Executive Officers  
 Geoffrey Cox, CEO          250K shares   722K options 
 John Green, CFO            109K shares   307K options 
 Harry Meade, SVP Research  107K shares   268K options 
 Dan Woloshen, Gen. Counsel  81K shares   190K options 
 Greg Liposky, SVP Oprtns    51K shares   246K options 
 Dick Scotland, SVP Regltry  67K shares   129K options 
 -- 
 Six executive officers     665K shares 1,852K options

 
 Independent directors  
 Robert Baldridge             5K shares    75K options 
 Kenneth Bauer                 0 shares    38K options 
 Christian Béchon             3K shares    15k options 
 Francis Bullock              5K shares    74K options 
 James Geraghty              70K shares   163K options 
 Michael Landine               0 shares    38K options 
 Pamela McNamara              6K shares    53K options 
 Marvin Miller                5K shares    53K options 
 Alan Tuck                   11K shares    51K options 
 -- 
 Nine independent directors 105K shares   560K options

 
 All officers/directors     770K shares 2,412K options